Body Weight  >>  roflumilast  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
roflumilast / Generic mfg.
RAMBO, NCT01701934: Impact of Roflumilast on Visceral Adiposity and Metabolic Profile in Chronic Obstructive Pulmonary Disease

Terminated
2
14
Canada
Roflumilast, DAXAS, Placebo, Inactive comparator
Laval University, Innovair, Takeda
Chronic Obstructive Pulmonary Disease, Metabolic Syndrome
10/14
12/14
NCT01862029: Effects of Roflumilast on Insulin and Blood Sugar Levels in Prediabetic Overweight and Obese Individuals

Completed
1/2
24
US
Roflumilast
National Heart, Lung, and Blood Institute (NHLBI)
Obesity
07/17
07/17

Download Options